Article Details

FDA Accepts GSK's Biologics License Application of Blenrep for Relapsed or Refractory ...

Retrieved on: 2024-12-02 19:42:08

Tags for this article:

Click the tags to see associated articles and topics

FDA Accepts GSK's Biologics License Application of Blenrep for Relapsed or Refractory .... View article details on hiswai:

Excerpt

Atrial fibrillation affects approximately three million people in the United States, with estimates predicting that it will affect more than 7.5 ...

Article found on: www.pharmexec.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up